Paisan Ruamviboonsuk

Chair(s): Shih Jen Chen (Chinese Taipei); Paisan Ruamviboonsuk (Thailand);

Topic: Medical Retina

Chair(s): Michael Chiang (United States); Dawn Sim (United Kingdom); Daniel Ting (Singapore);

Updates on deep learning for retinopathy of prematurity
Michael Chiang (United States)
The UK perspective on digital health and AI in retina disease
Dawn Sim (United Kingdom)
Digital health and AI in Retina Disease: The US perspective
Linda Lam (United States)
Unlock the power of color retinal photos with AI
Paisan Ruamviboonsuk (Thailand)
The Asian perspective on digital health and AI in retina disease
Daniel Ting (Singapore)

Topic: Medical Retina

Chair(s): Patricia Udaondo (United States); Paisan Ruamviboonsuk (Thailand); TBA;

Will bevacizumab still be used for management of wet AMD 5 years from now?
Baruch Kuppermann (United States)
Gene therapy for AMD
Allen Ho (United States)
Roles of OCTA for management of wet AMD
Shih Jen Chen (Chinese Taipei)
Brolucizumab into the current management of wet AMD
Srinivas Sadda (United States)
Management of neovascular AMD - present
Patricia Udaondo (United States)
AI for screening AMD: where are we now?
Paisan Ruamviboonsuk (Thailand)

Topic: Medical Retina

Chair(s): Paisan Ruamviboonsuk (Thailand); Matus Rehak (Germany);

Genetics, risk factors and epidemiology of myopia
Allen Ho (United States)
Pathological Myopia (new classification and natural course)
Kyoko Ohno-Matsui (Japan)
Multimodal imaging in myopia
Hiroko Terasaki (Japan)
Myopic CNV - Management
Shih Jen Chen (Chinese Taipei)
New technics in high myopic macular holes
Maria Berrocal (Puerto Rico)

Topic: Medical Retina